Veracyte | VCYT - 资产



金融业
股票价格
USD
资产
USD 1.41B
现金及等价物
USD 362.58M
销售成本
USD 39.29M
流动资产
USD 488.38M
流动负债
USD 59.94M
债务
USD 40.45M
EBIT
USD 24.63M
EBITDA
USD 42.31M
员工
824
EPS每股收益
USD 0.53
股本和储备
USD 1.26B
销售毛利
USD 101.97M
债务利息支出
USD 2K
利息收入
USD 3.48M
贷款资金
USD 0
市值
USD 2.5B
净收入
USD 41.15M
营业费用
USD 116.01M
营业利润
USD 24.63M
普通股股本
USD 79.05M
PE价格收益
45.3
税前利润
USD 40.63M
销售收入
USD 140.6M
销售和管理费用
USD 43.31M
股票
USD 20.55M
贸易债权人
USD 4.59M
应收帐款人
USD 44.66M


资产 更改 日
Agenus USD 226.8M 7.09M 2025-12
Agilent USD 12.81B 86M 2025-12
Anika Therapeutics USD 190.27M 833K 2025-12
Arrowhead Research USD 1.6B 218.89M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Exact Sciences USD 5.86B 39.38M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Illumina USD 6.64B 467M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Laboratory Of America USD 18.39B 131.1M 2025-12
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
Myriad Genetics USD 706.6M 21.5M 2025-12
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Siemens EUR 170.13B 3.93B 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Veracyte USD 1.41B 38.23M 2025-12
Waters USD 5.08B 221.41M 2025-12